AcuityMD, a Boston-based provider of AI-powered solutions for the medical technology sector, announced an $80 million round of Series C funding led by StepStone Group. The company works to provide up-to-date commercial insights for medtech organizations.
“AI will transform medtech, but only with the right context, deeply embedded in the workflows where decisions are made. AcuityMD is that context layer, serving the rep in the field, the commercial leader planning territories and the teams launching the next generation of innovation,” Mike Monovoukas, AcuityMD’s CEO and co-founder, said in a statement. “This funding accelerates our shared mission of accelerating adoption of cutting-edge medical technologies.”
The company’s platform aggregates disparate information across claims databases, FDA filings, government records and market signals and gives organizations a knowledge graph that maps entities like physicians, facilities and networks as well as their relationships. This ontology integrates with an organization’s internal data, equipping them with a continually updated view of the healthcare market. The AcuityAI solution is built on this foundation.
With its new funding, AcuityMD will focus on accelerating its agentic AI capabilities for sales reps, marketing teams and other commercial functions. It will also further the ontology that powers its data model and expand its platform beyond the commercial segment.
